Short-term administration of bovine somatotropin to lactating dairy cows in a subtropical environment

Our objective was to evaluate response of lactating dairy cows to daily injections of bovine somatotropin during a subtropical summer. Ten Holstein cows, averaging 196 d in lactation, were used in a 30-d study. No treatment was imposed during d 1 to 10 (period 1) and d 21 to 30 (period 3). During d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of dairy science 1988-12, Vol.71 (12), p.3274-3282
Hauptverfasser: Staples, C. R, Head, H. H, Darden, D. E
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Our objective was to evaluate response of lactating dairy cows to daily injections of bovine somatotropin during a subtropical summer. Ten Holstein cows, averaging 196 d in lactation, were used in a 30-d study. No treatment was imposed during d 1 to 10 (period 1) and d 21 to 30 (period 3). During d 11 to 20 (period 2), cows were injected daily with either 0 or 59 IU of pituitary-derived bovine somatotropin in 30 ml solution. Dry matter intake and milk yield and composition were measured daily. Jugular blood samples, taken on d 10, 15, 20, and 30, were analyzed for insulin, nonesterified fatty acids, urea nitrogen, and insulin-like growth factor-1. Body temperatures and respiration rates were measured at 1400 h on 4 or 5 d during each 10-d period. Data were analyzed using orthogonal contrasts. Contrast of period 1 plus period 3 vs. period 2 for treatment X days interaction was significant for milk yield, respiration rate, serum nonesterified fatty acids, and insulin-like growth factor-1. Under heat stress, cows injected with bovine somatotropin for 10 d produced 9.3% more milk than control cows with no change in feed intake. This increased production was accompanied by higher respiration rates (6%) and higher concentrations of serum nonesterified fatty acids (150%) and insulin-like growth factor-1 (222%).
ISSN:0022-0302
1525-3198
DOI:10.3168/jds.S0022-0302(88)79932-4